Using Gout Buddy to Enhance Gout Management

Launched by SINGHEALTH POLYCLINICS · May 26, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new tool called Gout Buddy, which is an AI chatbot designed to help people manage their gout better by providing personalized dietary education. Gout is a type of arthritis that can cause painful attacks, often linked to diet. Many patients find it hard to understand the complex dietary guidelines needed to manage their condition. The trial will compare the effectiveness of Gout Buddy with standard care to see if it improves patients' understanding of diet and their ability to manage gout.

To participate in this trial, you need to be over 21 years old, have had high uric acid levels or a gout attack in the last 18 months, and be able to read and speak English. You also need access to the internet and a device compatible with Gout Buddy. If you join, you'll attend two study visits over 3 to 6 months, where you'll share your experiences with Gout Buddy and how it has helped you manage your condition. This trial aims to show how helpful AI tools can be in improving self-management for people with chronic diseases like gout, potentially leading to better health outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age \> 21 years
• • At least one serum uric acid \> 360 μmol/L or an episode of acute gout attack within the last 18 months
• • Able to read and speak English
• • Access to an internet-enabled device compatible with Gout Buddy
• Exclusion Criteria:
• • Not a Singapore citizen or permanent resident
• • Pregnant
• • End-stage kidney disease or on renal replacement therapy
• • Known terminal illness
• • Visual and/or hearing impairment
• • Cognitive impairment or mental illness
• • Unable to provide informed consent
• • Individuals who do not have a personal mobile device with internet access